I Treat Cholesterol Differently Now: Statins, PCSK9s, Ezetimibe & Gene Editing
In a Nutshell
The core message is that aggressive LDL/apoB lowering has no floor and delivers exponential cardiovascular benefit when started early and sustained lifelong. Most patients can reach very low targets with cheap, generic combinations—high-intensity statin plus ezetimibe—and those who are statin-intolerant or still short of goal now have well-tolerated, once- or twice-yearly injectables (PCSK9 antibodies, inclisiran, bempedoic acid) that cut LDL another 50 % or more. Emerging one-time gene-editing therapies (Verve-101) and multiple Lp(a)-specific agents in late-stage trials promise permanent or near-permanent solutions within the next decade.
These notes were generated by AI and may contain inaccuracies.
One infusion and your cholesterol drops 60% permanently. The gene causing the problem gets edited and you never need a statin or injection ever again. This is real and it's in trials right now, fully enrolled with phase one data published and peer-reviewed. And if the safety holds, some of you watching this could be in the first generation of people who could say, "I fixed my cholesterol once and done."
If you've been diagnosed with high cholesterol or atherosclerosis or you just had a cardiac event or if you are like so many of us who have watched our parents and grandparents battle this disease, you deserve to know what the ceiling of what's possible actually looks like. My grandfather died of a stroke. My grandmother died of sudden cardiac arrest. My aunt died of aortic dissection and my father, while I'm recording this, is still recovering from a heart transplant. All on my paternal side. When my own Ava became back at 128, I was scared. I'm a Stanford-trained physician and I've been practicing for over a decade. I know exactly how to read the data and what matters and what doesn't. I still had a moment where I sat with that result and thought, "Okay, now it's my turn."
So, here is what I did and everything I considered and what you should know about your options from a $4 generic that has more clinical evidence behind it than almost any drug developed to a twice-a-year injection most patients have never heard of to a gene-editing therapy very close to reality. Quick orientation, this is part three of the modern lipid playbook. In part one, we covered the disease. Part two was how to test properly. Links are in the description. Each video stands alone. Now, this video, part three, is for you if you've just gotten a statin prescription and you went home and spent three hours reading terrifying things on the internet. This is for you if you've tried one and stopped because of muscle pain. And this is especially for you if you're doing everything right but your lipids are still high because for many of us, this is not a lifestyle failure. It's genetics. And that change everything about what drugs you need.
Sign in to read the full notes
Get access to AI-generated notes, topic timestamps, and more.